Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Suicidal risk in bipolar disorders]

M L Bourgeois1, H Verdoux

  • 1IPSO: Université Victor Segalen, Bordeaux II.

L'Encephale
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Patients with mood disorders face higher mortality risks. Long-term lithium treatment significantly reduces this risk in bipolar disorder, but more research is needed for other mood stabilizers and the bipolar spectrum.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Effectiveness of peer helper interventions for people with schizophrenia or bipolar disorder: A literature review].

L'Encephale·2022
Same author

Maternal post-natal depressive symptoms at 2 months: Effects of French antenatal preventive measures in the E.L.F.E. cohort.

Journal of affective disorders·2021
Same author

Being parent is associated with suicidal history in people with serious mental illness enrolled in psychiatric rehabilitation.

Journal of psychiatric research·2021
Same author

Stigma resistance is associated with advanced stages of personal recovery in serious mental illness patients enrolled in psychiatric rehabilitation.

Psychological medicine·2020
Same author

Educational needs and psychoeducation interventions in clozapine users: a narrative review.

Acta psychiatrica Scandinavica·2020
Same author

[Electroconvulsive therapy in combination with psychotropic and non-psychotropic pharmacological treatments: Review of the literature and practical recommendations].

L'Encephale·2020
Same journal

Measuring antidepressant side effects in military personnel - Clinical validation of the French version of the UKU-SERS-Pat Scale: A comparative study of patient and clinician ratings.

L'Encephale·2026
Same journal

[Empowerment in addictology].

L'Encephale·2026
Same journal

Evaluation of the links between smoking and conspiracy mentality.

L'Encephale·2026
Same journal

Use of a relevance assessment tool in therapeutic residential care: A real world study.

L'Encephale·2026
Same journal

Prevalence and characteristics of domestic violence in a sample of adult psychiatric outpatients: A cross-sectional study.

L'Encephale·2026
Same journal

From representations to practice: how professionals describe supporting parents with psychiatric or somatic illness or disability.

L'Encephale·2026
See all related articles

Area of Science:

  • Psychiatry and Neuroscience
  • Clinical Pharmacology

Context:

  • Mood disorders, including bipolar disorder, are associated with significantly elevated mortality and morbidity rates.
  • Suicide and cardiovascular diseases are leading causes of premature death in these patients.
  • Existing research highlights the protective effect of long-term lithium treatment against mortality in bipolar disorder.

Purpose:

  • To review the impact of mood stabilizers on mortality and morbidity in mood disorders.
  • To identify gaps in research regarding the long-term efficacy of newer mood stabilizers and treatments for the broader bipolar spectrum.

Summary:

  • Long-term lithium therapy demonstrably reduces morbidity in bipolar disorder patients to general population levels.
  • Data on the long-term prophylactic effects of other mood stabilizers (e.g., valpromide, carbamazepine) on mortality are lacking.

Related Experiment Videos

  • Further investigation is required for conditions like bipolar II, mixed states, dysphoric mania, and the "bipolar spectrum" (soft bipolar pathology).

    • Impact:

    • Highlights the critical need for long-term outcome data on mood stabilizers beyond lithium.
    • Emphasizes the importance of addressing the high mortality associated with mood disorders.
    • Guides future research priorities in mood disorder pharmacotherapy and the understanding of the bipolar spectrum.